Defining the therapeutic reference range for cariprazine
Introduction According to the Consensus Guideline, the “therapeutic reference range” (TRR) defines ranges of drug blood concentrations that specify a lower limit below which a drug-induced therapeutic response is unlikely to occur and an upper limit above which tolerability decreases or the therape...
Main Authors: | M. Kapás, A. Horváth, D. Djuric, R. Csehi, Á. Barabássy |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823011781/type/journal_article |
Similar Items
-
The Role of Partial Agonists and Specifically Cariprazine in Dual Disorders
by: Á. Barabássy, et al.
Published: (2024-04-01) -
Benzodiazepine use during cariprazine treatment in acute schizophrenia
by: C. Correll, et al.
Published: (2022-06-01) -
Exploring Cariprazine’s Potential in Late-Stage Schizophrenia Treatment
by: P. Falkai, et al.
Published: (2024-04-01) -
Relapse prevention with cariprazine in patients with early-stage schizophrenia
by: C. U. Correll, et al.
Published: (2024-04-01) -
Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials
by: R. Mcintyre, et al.
Published: (2022-06-01)